Nabil M. Ahmed,Stephen M. G. Gottschalk,Winfried Wels
申请号：
US15558596
公开号：
US20180079824A1
申请日:
2016.03.18
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Embodiments of the disclosure include immune cells expressing HER2-specific chimeric antigen receptors (CAR) and treatment of cancer therewith. In specific embodiments, sarcoma or glioblastoma are treated. In specific embodiments, such as for glioblastoma, for example, T-cells expressing a HER2-specific CAR are pp65CMV-specific T cells.
